Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study

por Bunch, T. Jared, Jacobs, Victoria, May, Heidi, Stevens, Scott M., Crandall, Brian, Cutler, Michael, Day, John D., Mallender, Charles, Olson, Jeff, Osborn, Jeffrey, Weiss, J. Peter, Woller, Scott C.
Publicado 2019

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19

por Cutler, Michael J., May, Heidi T., Bair, Tami L., Crandall, Brian G., Osborn, Jeffrey S., Miller, Jared D., Mallender, Charles D., Muhlestein, Joseph B., Anderson, Jeffrey L., Knowlton, Kirk U., Knight, Stacey
Publicado 2022

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other I...

por Bunch, T. Jared, May, Heidi T., Bair, Tami L., Crandall, Brian G., Cutler, Michael J., Day, John D., Jacobs, Victoria, Mallender, Charles, Osborn, Jeffrey S., Stevens, Scott M., Weiss, J. Peter, Woller, Scott C.
Publicado 2016